Clinical Trial Committee
Clinical Trials Technical Committee
The Clinical Trials Technical Committee (CTTC) has been established by Director General under Section 13 of TMDA Act, Cap 219 in order to provide independent technical advice to Director General.
Members of the CTTC provide technical advice to assure that clinical trials are designed, conducted, analyzed and reported in accordance with TMDA and ICH guidelines. In this respect, their recommendations are expected to be scientific and evidence based.
Members of the Clinical Trial Technical Committee (CTTC) are expected to be prudent, transparent, independent, and committed to their professional ethics while discussing all matters pertaining to clinical trials.
Composition of Committee
The CTTC is composed of experts with knowledge and experience in at least the following fields:-
- Clinical Trials
- Medical Research
- Clinical Pharmacology
- Clinica Epidemiology
- Dental Surgery
- Medical Statistics
- Public Health
- Regulatory Affairs
The CTTC meets once quarterly and the current members are as listed in the table;
|1.||Ms. Joyce Ikingura||Chair Person||Research ethics/ Bioethics|
|2.||Mr. Akida M. Khea||Secretary||Regulatory Affairs|
|3.||Dr. Billy Ngasala||Member||Parasitology and Medical Entomology|
|4.||Prof. Mecky Matee||Member||Microbiology|
|5.||Dr. Omar Lweno||Member||Medical Research/ Clinical Trials|
|6.||Dr. Jenifa Metodi||Member||Paediatrics|
|7.||Dr. Mwanaidi Kafuye||Member||Research ethics/ Bioethics|
|8.||Dr. Doreen Mloka||Member||Pharmaceutical Microbiology|
|9.||Prof. John Lusingu||Member||Medical Research/Clinical Trials|
The Committee serves for three (3) years and the tenure of the current Committee will come to an end on 31st January 2022.